Viewing Study NCT00881751

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:53 PM

Ignite Modification Date: 2025-12-25 @ 9:49 PM

Study NCT ID: NCT00881751

Status: COMPLETED

Last Update Posted: 2017-09-11

First Post: 2009-04-14

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Sponsor: Medical University of South Carolina

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module